Kyowa Kirin
Highly Engaged Employees
Highly Engaged EmployeesManufacturing · Japan · 5K - 10K Employees
View Company Info for Free
Overview
Headquarters
Otemachi Financial City Grand Cube 1-9-2...Phone Number
+81 352057200Website
www.kyowakirin.comRevenue
$3 BillionStock Symbol
KYKOFIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
5
1
1
1
1
1
About Kyowa Kirin
Kyowa Kirin is a global specialty pharmaceutical company focused on antibody research and engineering to address the needs of patients and society across multiple therapeutic areas, including Nephrology, Oncology, Immunology/Allergy and Neurology. They are headquartered in Tokyo, Japan.Explore more
Kyowa Kirin Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Kyowa Kirin your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Kyowa Kirin, which may be a good buyer, showed buying intent in Masked Content Topic
Funding: Get notified immidiatlly once Kyowa Kirin has new funding data
Product Launch: Get notified when Kyowa Kirin launches new products
Click to see if Kyowa Kirin had a recent Job posting/layoffs
Congratulate Masked Content for being promoted to Masked Content at Kyowa Kirin
Check if Kyowa Kirin has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Check out if Kyowa Kirin is spiking on competitors!
Earning: See what the market has to say on Kyowa Kirin recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Company Profile Activity
Activity Insights
Kyowa Kirin is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
Kyowa Kirin is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about Kyowa Kirin.
Kyowa Kirin Tech Stack
A closer look at the technologies used by Kyowa Kirin
See more technologies
Most Recent Scoops
Person-Based
Events, Medical Research, Pharmaceuticals, Clinical Operations
Person-Based
Public Health, Patient Experience
Person-Based
Corporate Strategy
Person-Based
Research & Development, Pharmaceuticals
Person-Based
Financial Planning
Kyowa Kirin News & Media
New Analyses Advance Understanding of Long-Term Survival Outcomes with Mogamulizumab in Mycosis Fungoides and Sézary Syndrome
PRINCETON, N.J., June 30, 2026 (GLOBE NEWSWIRE) -- Researchers at the World Congress of Cutaneous Lymphoma 2026 presented two indirect treatment comparison (ITC) analyses examining the impact of mogamulizumab on long-term outcomes, including overall survival (OS), in patients with relapsed or refractory mycosis fungoides (MF) or Sézary syndrome (SS), two subtypes of cutaneous T-cell lymphoma (CTCL). These findings, which drew on clinical trial and real-world data, expand the growing body of evidNew PROSPER Data Demonstrate Real-World Impact of Mogamulizumab on Symptoms and Health-Related Quality of Life in Mycosis Fungoides and Sézary Syndrome
PRINCETON, N.J., June 29, 2026 (GLOBE NEWSWIRE) -- Kyowa Kirin, Inc., a wholly owned subsidiary of Kyowa Kirin Co. Ltd (TSE: 4151), today announced positive results from PROSPER, a real-world observational study of mogamulizumab in adults with mycosis fungoides (MF) or Sézary syndrome (SS). In the study, patients reported clinically meaningful improvements in skin symptoms (itch, flaking, and redness) and body temperature regulation as early as week 4, with improvements in sleep and health-relatThe XLH Network and Kyowa Kirin Launch the XLH Community Guidebook to Help People Navigate Lifelong Journey with XLH
New online resource brings together practical information, community perspectives, and expert guidance tailored to people with XLH across ages and life stages New online resource brings together practical information, community perspectives, and expert guidance tailored to people with XLH across ages and life stagesKura Oncology And Kyowa Kirin Report Encouraging Long-Term Results for Ziftomenib / 7+3 Combination In Newly Diagnosed AML
– 12-month OS rate 94% among NPM1-m AML patients and 71% among KMT2A-r AML patients in single-arm KOMET-007 trial –
Read more news
Top Manufacturing Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Kyowa Kirin
Sign Up For FreeTo access detailed company insights
Kyowa Kirin is a global specialty pharmaceutical company focused on antibody research and engineering to address the needs of patients and society across multiple therapeutic areas, including Nephrology, Oncology, Immunology/Allergy and Neurology. They are headquartered in Tokyo, Japan.... Read More
